🇺🇸 FDA
Patent

US 10792287

Methods for treating mitochondrial diseases

granted A61KA61K31/122A61K31/137

Quick answer

US patent 10792287 (Methods for treating mitochondrial diseases) held by The Regents of the University of California expires Mon Oct 01 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Oct 06 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 01 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61K, A61K31/122, A61K31/137, A61K31/155, A61K31/436